PhiTech

2 known investors

PhiTech provides an AI-powered multi-omics platform for genomic and transcriptomic analysis that accelerates diagnosis of rare diseases and hereditary cancers. The platform integrates whole-exome/whole-genome sequencing and RNA-Seq data with proprietary AI to prioritize disease-causing genes for diagnostic laboratories, hospitals, clinics, and academic research centers.